Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Diazepam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Alveolar Soft Part 1

Interventions

Cyclophosphamide 345 Specimen Handling 326 Magnetic Resonance Spectroscopy 282 Radiotherapy 274 Biopsy 239 Cisplatin 229 Carboplatin 219 Paclitaxel 196 Doxorubicin 195 Fluorouracil 177 Etoposide 175 Vincristine 165 Bevacizumab 165 Filgrastim 154 Gemcitabine 147 Leucovorin 134 Cytarabine 130 aldesleukin 127 Docetaxel 108 fludarabine phosphate 101 Taxes 100 Oxaliplatin 100 Chemotherapy, Adjuvant 99 Rituximab 98 Prednisone 92 Methotrexate 92 Irinotecan 91 Radiation 90 Bortezomib 89 Dexamethasone 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

34 enrolled 22 charts

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡